Skip to content
Open access

Deep learning-based histologic classifiers enable molecular subtyping of metastatic prostate cancer.

Aug 2026 · JCI Insight · Vol 11 · 0 citations
Medicine

TL;DR

A deep learning model that leverages interpretable cellular features to improve feature extraction from H&E-stained tissue sections (NEURAL-PC) and represents an extensively validated diagnostic and prognostic model for advanced prostate cancer.

Abstract

Metastatic prostate cancer is a clinically and molecularly heterogeneous disease. Under the selective pressure of androgen receptor (AR)-directed therapies, resistant phenotypes frequently emerge, posing significant diagnostic and therapeutic challenges. Neuroendocrine prostate cancer (NEPC) is a clinically important phenotype characterized by lineage plasticity, neuroendocrine features, visceral metastases and poor prognosis. Accurately diagnosing NEPC remains difficult due to its histologic and molecular complexity but has high clinical relevance. In this study, we developed a deep learning model that leverages interpretable cellular features to improve feature extraction from H&E-stained tissue sections (NEURAL-PC). By incorporating a multiple instance learning (MIL) framework, NEURAL-PC enables robust NEPC classification solely from H&E tumor images, achieving an area under the receiver operating characteristic curve (AUROC) of 0.921 in independent external validation. In addition to its diagnostic utility, NEURAL-PC provides prognostic information that enables further subclassification of advanced prostate cancer across diverse datasets supporting its strong prognostic value and generalizability. Broadly, our work highlights a hybrid approach that integrates features across different domains, offering a promising strategy for developing reliable deep learning tools in pathology. Built on this framework, NEURAL-PC represents an extensively validated diagnostic and prognostic model for advanced prostate cancer.

Read PDF

Similar papers

Open access Sep 2026

Deep Learning-Based Multi-Cancer Analysis for Predicting Disease-Free Survival Across Multiple Cancer Types

The deep learning-based multi-cancer disease-free survival model performed robustly across cancer subtypes, with the nomogram improving risk stratification, particularly for stage I malignancies, complementing existing staging.

Si-Teng Chen, En-Cheng Zhang, Fu-Kang Sun et al. · 0 citations
#explainable ai Review Open access Sep 2026

Artificial intelligence in non-small cell lung cancer: transforming diagnosis, treatment, and prognostic evaluation

Non-small cell lung cancer (NSCLC) is characterized by profound biological heterogeneity, frequently leading to late-stage diagnosis, recurrence, or metastasis. Conventional clinical pathways heavily depend on subjective visual interpretations, invasive tissue biopsies, and experience-based medical models that constrai...

Shuai-Yu Zheng, Chi Lv, Zhen Yao · 0 citations
Open access Sep 2026

Molecular subtyping of breast cancer from routine Hematoxylin & Eosin-stained histology images using deep learning.

INTRODUCTION Breast cancer is a heterogeneous malignancy comprising distinct molecular subtypes, each with varying therapeutic strategies and prognoses. Conventional molecular subtyping relies on immunohistochemistry and in situ hybridization studies, which may not be universally accessible due to financial and technic...

Mehdi Zarei, M. Arabfard, Mehdi Raei et al. · 0 citations
#explainable ai Review Open access Sep 2026

Melanoma Prognostication Using AI‐Guided Histopathology

This review examines how computational pathology and convolutional neural networks (CNNs) can improve histopathologic diagnosis and risk stratification of melanoma, evaluate current image-based deep learning (DL) approaches, and outline a path toward explainable, multimodal prognostic tools.

Eudora Lee, R. Karagenova, Y. Semenov · 1 citation
Open access Sep 2026

Predicting Tumor Mutational Burden in Prostate Cancer Using Deep Learning on Histopathological Images

It is suggested that deep learning models, particularly Inception V3, can effectively predict TMB status in patients using histopathological images, and the potential for integrating DL techniques in clinical settings to enhance personalized treatment strategies for patients with varying TMB is highlighted.

T. A. Serel, Onur Ertunç, M. Kıran et al. · 0 citations
Aug 2026

P1.108. Molecular Determinants of Tumor Morphology in Esophageal Adenocarcinoma

The first validated morpho-molecular classification of Esophageal adenocarcinoma is reported, with the transitional and signet ring signatures associated with worse prognosis compared to tumors with a glandular signature.

G. Wilson, Jin-soo Park, F. Allison et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.